pmid,title,journal,year,drug,disease
40745453,Telomere Dynamics in Cardiovascular Aging: From Molecular Mechanisms to Precision Medicine.,Cardiology in review,2025,Dasatinib,Heart Failure
40618973,Human heart-on-a-chip model emulates structural and functional characteristics of diastolic dysfunction and reveals a beneficial role for senolytics.,Acta biomaterialia,2025,Dasatinib,Heart Failure
40065794,Dasatinib-Induced Pulmonary Arterial Hypertension in Chronic Myeloid Leukaemia: A Case Report and Literature Review.,Respirology case reports,2025,Dasatinib,Heart Failure
39102426,SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure.,PLoS pathogens,2024,Dasatinib,Heart Failure
38802411,Exploring the pathways of drug repurposing and Panax ginseng treatment mechanisms in chronic heart failure: a disease module analysis perspective.,Scientific reports,2024,Dasatinib,Heart Failure
38090129,Antisenescence Therapy Improves Function in a Human Model of Cardiac Fibrosis-on-a-Chip.,ACS materials Au,2023,Dasatinib,Heart Failure
37996554,Exploring potential therapeutic agents for lipopolysaccharide-induced septic cardiomyopathy based on transcriptomics using bioinformatics.,Scientific reports,2023,Dasatinib,Heart Failure
37880106,Potential Clinical Implications of Senotherapies for Cardiovascular Disease.,Circulation journal : official journal of the Japanese Circulation Society,2024,Dasatinib,Heart Failure
37358999,A practical guide to managing cardiopulmonary toxicities of tyrosine kinase inhibitors in chronic myeloid leukemia.,Frontiers in medicine,2023,Dasatinib,Heart Failure
37152411,Dasatinib targets c-Src kinase in cardiotoxicity.,Toxicology reports,2023,Dasatinib,Heart Failure
36824461,"Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network.",Frontiers in cardiovascular medicine,2023,Dasatinib,Heart Failure
36385736,Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug Administration.,Pediatric blood & cancer,2023,Dasatinib,Heart Failure
36285576,"Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.",British journal of clinical pharmacology,2023,Dasatinib,Heart Failure
36230609,Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.,Cancers,2022,Dasatinib,Heart Failure
36184120,Imatinib induces diastolic dysfunction and ventricular early-repolarization delay in the halothane-anesthetized dogs: Class effects of tyrosine kinase inhibitors.,Journal of pharmacological sciences,2022,Dasatinib,Heart Failure
35402127,Effective collaboration between hematologists and cardiologists facilitated successful control of reversible dasatinib-related pulmonary arterial hypertension and treatment-free remission of chronic myeloid leukemia: a case report.,International cancer conference journal,2022,Dasatinib,Heart Failure
35152199,Cardiovascular Toxicity Associated With Tyrosine Kinase Inhibitor Therapy In Chronic Myeloid Leukemia.,The Gulf journal of oncology,2021,Dasatinib,Heart Failure
35083382,Comparison of Dasatinib- and Imatinib-Related Cardiotoxic Adverse Events in Japanese Patients With Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor.,Circulation reports,2022,Dasatinib,Heart Failure
35015312,Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.,American journal of hematology,2022,Dasatinib,Heart Failure
34826413,"Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial.",The Lancet. Haematology,2021,Dasatinib,Heart Failure
33376527,Genome-wide prioritization reveals novel gene signatures associated with cardiotoxic effects of tyrosine kinase inhibitors.,Oncology letters,2021,Dasatinib,Heart Failure
33068232,Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors.,Cardiovascular toxicology,2021,Dasatinib,Heart Failure
33050924,Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).,Trials,2020,Dasatinib,Heart Failure
32768078,A 59-Year-Old Woman With Shortness of Breath and Chest Pain.,Chest,2020,Dasatinib,Heart Failure
32235443,Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS).,Cancers,2020,Dasatinib,Heart Failure
32152879,Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease.,International journal of hematology,2020,Dasatinib,Heart Failure
31848139,Chylothorax: complication attributed to dasatinib use.,BMJ case reports,2019,Dasatinib,Heart Failure
31416783,The efficacy of tolvaptan in treating dasatinib-induced pleural effusions in patients with chronic myelogenous leukemia.,Journal of cardiology,2020,Dasatinib,Heart Failure
30730747,Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival.,Journal of proteome research,2019,Dasatinib,Heart Failure
29975149,"Dasatinib induces gene expression of CYP1A1, CYP1B1, and cardiac hypertrophy markers (BNP, beta-MHC) in rat cardiomyocyte H9c2 cells.",Toxicology mechanisms and methods,2018,Dasatinib,Heart Failure
29466183,[Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].,Kardiologiia,2017,Dasatinib,Heart Failure
29446053,Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors.,Journal of pharmacokinetics and pharmacodynamics,2018,Dasatinib,Heart Failure
29287600,Pulmonary arterial hypertension in a patient treated with dasatinib: a case report.,Journal of medical case reports,2017,Dasatinib,Heart Failure
28639957,Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.,Current opinion in pulmonary medicine,2017,Dasatinib,Heart Failure
28098949,Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.,British journal of clinical pharmacology,2017,Dasatinib,Heart Failure
34306297,Drug-Induced Pulmonary Hypertension: The First 50 Years.,Advances in pulmonary hypertension,2017,Dasatinib,Heart Failure
30167550,Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease.,JACC. Basic to translational science,2016,Dasatinib,Heart Failure
27599415,[Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia].,[Rinsho ketsueki] The Japanese journal of clinical hematology,2016,Dasatinib,Heart Failure
27263788,[Reversible dasatinib-related pulmonary arterial hypertension in a CML patient].,[Rinsho ketsueki] The Japanese journal of clinical hematology,2016,Dasatinib,Heart Failure
27003817,Linking MedDRA((R))-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.,Drug safety,2016,Dasatinib,Heart Failure
26785036,Heart failure associated with small molecule tyrosine kinase inhibitors.,International journal of cardiology,2016,Dasatinib,Heart Failure
26725357,[Achievement of deep molecular response in an elderly chronic myeloid leukemia patient intolerant to imatinib and nilotinib].,[Rinsho ketsueki] The Japanese journal of clinical hematology,2015,Dasatinib,Heart Failure
26458186,Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model.,PloS one,2015,Dasatinib,Heart Failure
26256879,[Development of Ph negative acute myeloid leukemia in a patient with minor-BCR/ABL positive chronic myeloid leukemia achieving a partial cytogenetic response during tyrosine kinase inhibitor treatment].,[Rinsho ketsueki] The Japanese journal of clinical hematology,2015,Dasatinib,Heart Failure
26978425,"[FIP1L1-PDGFRcapital A, Cyrillic-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy].",Terapevticheskii arkhiv,2015,Dasatinib,Heart Failure
25052596,[Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review].,Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,2014,Dasatinib,Heart Failure
24807266,Ponatinib: a review of its use in adults with chronic myeloid leukaemia or Philadelphia chromosome-positive acute lymphoblastic leukaemia.,Drugs,2014,Dasatinib,Heart Failure
23972547,Drugs induced pulmonary arterial hypertension.,"Presse medicale (Paris, France : 1983)",2013,Dasatinib,Heart Failure
20399520,Cardiac side-effects of cancer chemotherapy.,International journal of cardiology,2010,Dasatinib,Heart Failure
19734999,Cardiotoxicity induced by tyrosine kinase inhibitors.,"Acta oncologica (Stockholm, Sweden)",2009,Dasatinib,Heart Failure
